A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor
Title:
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor
Author:
Vincenti, Flavio Budde, Klemens Merville, Pierre Shihab, Fuad Ram Peddi, V. Shah, Malay Wyburn, Kate Cassuto-Viguier, Elisabeth Weidemann, Alexander Lee, Misun Flegel, Teresa Erdman, Jay Wang, Xuegong Lademacher, Christopher
Appeared in:
American journal of transplantation
Paging:
Volume 18 () nr. 12 pages 2945-2954
Year:
2018
Contents:
Publisher:
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.